N-去乙酰秋水仙碱

(7S)-7-amino-1,2,3,10-tetramethoxy-6,7-dihydrobenzo[a]heptalen-9(5H)-one

≥98%

(S)-雷贝拉唑钠盐

(S)-Rabeprazole Sodium Salt

(4R,5S)-4,5-二苯基-2-噁唑烷酮, 99%

(4R,5S)-4,5-Diphenyl-2-oxazolidinone

速甾醇

(6E,22E)-(3R)-9,10-secoergosta-5(10),6,8,22-tetraen-3-ol

≥90%

(S)-(+)-扁桃酸甲酯, 98%

Methyl (S)-(+)-mandelate

2,3-双[（2R，5R）-2,5-二甲基膦酰基]-N-[3,5-双（三氟甲基）-苯基]马来酰亚胺

2,3-Bis[(2R,5R)-2,5-dimethylphospholano]-N-[3,5-bis(trifluoromethyl)-phenyl]maleimide

(S)-(+)-5,5-二甲基-4-苯基-2-恶唑烷酮, 99%

(S)-Phenyl superquat

反式-4-（2-丙烯基）环己烷甲酸甲酯

trans-4-(2-Propynyl)cyclohexanecarboxylic Acid Methyl Ester

乙炔雌二醇双乙酸酯

Ethynylestradiol Diacetate

1-[（（1S）-1-（羟甲基）丙基]-2-吡咯烷酮

1-[(1S)-1-(Hydroxymethyl)propyl]-2-pyrrolidinone

2′-O-（叔丁基二甲基甲硅烷基）紫杉醇

2'-O-(tert-Butyldimethylsilyl)taxol

Methyl 2-(S)-Acetoxy-3-carboxypropanoate

Methyl 2-(S)-Acetoxy-3-carboxypropanoate

1-羟基-2,7-二氨基米托烯（顺/反混合物）

1-Hydroxy-2,7-diamino Mitosene (Mixture cis/trans)

(R)-4-苄基噁唑烷-2-硫酮, ≥99%,≥99.9% e.e.

(R)-4-Benzyloxazolidine-2-thione

(4S,5R)-(-)-4-甲基-5-苯基-2-噁唑烷酮, 99%

(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one

(R)-4-苯基噁唑烷-2-硫酮, ≥99%,≥99.9% e.e.

(R)-4-Phenyloxazolidine-2-thione

R-4-苄基-2-恶唑烷酮, 99%

R-4-Benzyl-2-oxazolidinone

(R)-(+)-3-(苄氧羰基)-4-恶唑烷羧酸

(R)-(+)-3-(benzyloxycarbonyl)-4-oxazolid-inecarbo

98%

3-庚基-4-（S）-异丙基-恶唑烷-2-

3-Heptanoyl-4-(S)-isopropyl-oxazolidin-2-one

(S)-(-)-3-(苄氧羰基)-噁唑烷-4-羧酸

(S)-(-)-3-(benzyloxycarbonyl)-4-oxazolid-inecarbo

99%